ArticleDiabetologia2024

Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease.

Donna S-H Lin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.